Tech Company Financing Transactions
Merck Funding Round
On 11/4/2025, Merck raised $700 million in investment from Blackstone.
Transaction Overview
Company Name
Announced On
11/4/2025
Transaction Type
Venture Equity
Amount
$700,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2000 Galloping Hill Rd.
Kenilworth, NJ 07033
USA
Kenilworth, NJ 07033
USA
Phone
Website
Email Address
Overview
Merck & Co., Inc. (NYSE: MRK) provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Frazier
Chief Financial Officer
Robert Davis
Executive Vice President
Richard DeLuca
Executive Vice President
Julie Gerberding
VP - General Counsel
Jennifer Zachary
VP - Manufacturing
Sanat Chattopadhyay
VP - R & D
Roger Perlmutter
Browse more venture capital transactions:
Prev: 11/4/2025: Donut Labs venture capital transaction
Next: 11/4/2025: Ruli.ai venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs